Asthma is a heterogeneous chronic disease characterized by narrowing of airways of the lungs and can lead to debilitating symptoms. Type 2 inflammation in asthma is noted by the release of inflammatory cytokines, including interleukin (IL)-4, IL-5, and IL-13. These cytokines can activate eosinophils, which are produced in bone marrow and can migrate to the lungs, causing asthma symptoms.
Several biomarkers have recently been identified to play a role in the mechanisms underlying type 2 airway inflammation, including fractional exhaled nitric oxide (FeNO), serum IgE, periostin, and blood and sputum eosinophils. These severe asthma type 2 cytokines are currently being studied as potential therapeutic drug targets.
How much do you know about type 2 inflammation in severe asthma? Test your knowledge with this quick quiz.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Zab Mosenifar. Fast Five Quiz: Type 2 Inflammation in Severe Asthma - Medscape - Jan 20, 2021.
Comments